Success Metrics

Clinical Success Rate

80.0%

Based on 4 completed trials

Completion Rate

80%(4/5)

Active Trials

5(45%)

Results Posted

75%(3 trials)

Terminated

1(9%)

Phase Distribution

Ph phase_2

18%

Ph early_phase_1

Ph phase_1

55%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Early Phase 1First-in-human

1(11.1%)

Phase 1Safety & dosage

6(66.7%)

Phase 2Efficacy & side effects

2(22.2%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(6)

Completed(4)

Terminated(1)

Detailed Status

Completed4

Recruiting3

Active, not recruiting2

Not yet recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

Phase 2

Trials by Phase

Early Phase 11 (11.1%)

Phase 16 (66.7%)

Phase 22 (22.2%)

Trials by Status

not_yet_recruiting19%

terminated19%

recruiting327%

active_not_recruiting218%

completed436%

Recent Activity

5 active trials

Showing 5 of 11

recruitingphase_1

CBD for Pain Following Orthopedic Shoulder Surgery

NCT06381791

recruiting

Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy

NCT06113237

not_yet_recruitingphase_2

Clinical Trials (11)

Showing 11 of 11 trials

NCT06381791Phase 1

CBD for Pain Following Orthopedic Shoulder Surgery

Recruiting

NCT06113237

Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy

Recruiting

NCT06333041Phase 2

Study of Cannabidiol in Sanfilippo Syndrome

Not Yet Recruiting

NCT04517799Phase 2

Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism

Active Not Recruiting

NCT07001930Phase 1

Effects of Cannabidiol on Stress and Nicotine Withdrawal

Recruiting

NCT05772429

Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting

Active Not Recruiting

NCT05269706Phase 1

Investigation of the Pharmacokinetic Profile of CBD

Completed

NCT04231643Early Phase 1

Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolar Disorder Patients and Healthy Volunteers

Terminated

NCT04238754Phase 1

Oral Cannabidiol for Opioid Withdrawal

Completed

NCT02700412Phase 1

University of Alabama at Birmingham (UAB) Adult CBD Program

Completed

NCT02695537Phase 1

University of Alabama at Birmingham (UAB) Pediatric CBD Program

Completed

All 11 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 11